欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
SE/H/2025/003
药品名称
Rosuvastatin STADA
活性成分
Rosuvastatin calcium 20.0 mg
剂型
Film-coated tablet
上市许可持有人
STADA Arzneimittel AG Germany
参考成员国 - 产品名称
Sweden (SE)
互认成员国 - 产品名称
Italy (IT)
Finland (FI)
Denmark (DK)
Belgium (BE)
Rosuvastatine EG 20 mg filmomhulde tabletten
Luxembourg (LU)
Ireland (IE)
Austria (AT)
Rosuvastatin STADA 20 mg Filmtabletten
France (FR)
Spain (ES)
Portugal (PT)
许可日期
2014/01/31
最近更新日期
2025/01/14
药物ATC编码
C10AA07 rosuvastatin
申请类型
TypeLevel1:
[not specified]
TypeLevel2:
[not specified]
TypeLevel3:
[not specified]
TypeLevel4:
[not specified]
TypeLevel5:
[not specified]
附件文件下载
Final PL
|
1_3_1_PIL_common_en_nl_h_3114_001_004_cl
Date of last change:2024/09/06
Final Labelling
|
NL3114_5 inner Label text Rosuvastatin
Date of last change:2024/09/06
Final Labelling
|
NL3114_5 outer Label text Rosuvastatin
Date of last change:2024/09/06
PubAR
|
PAR_3114_dc_rosuvastatine_10 dec 2015
Date of last change:2024/09/06
PubAR Summary
|
PAR_3114_dc_rosuvastatine_10 dec 2015_summary ENG
Date of last change:2024/09/06
Final Product Information
|
PL_Rosuvastatin_NL3114_20190221_DL_cl
Date of last change:2024/09/06
Final SPC
|
SmPC_Rosuvastatin_NL3114_20190221_DL_cl
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase